Affordable Access

Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates.

Authors
Type
Published Article
Journal
Human gene therapy
Publication Date
Volume
16
Issue
12
Pages
1484–1503
Identifiers
PMID: 16390279
Source
Medline

Abstract

Statistics

Seen <100 times